Bonsity (teriparatide biosimilar)
/ China NT Pharma, Alvogen, Kamada, Ligand
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
July 09, 2024
Drugs for postmenopausal osteoporosis.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Review • Osteoporosis • Rheumatology
July 09, 2024
Comparison table: Some drugs for postmenopausal osteoporosis.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Osteoporosis • Rheumatology
May 19, 2022
Treatment sequence key for optimal management of osteoporosis
(Healio)
- "'All osteoanabolic agents have been shown to reduce fractures and to increase bone mass and calculated hip bone strength. However, after they are used, both bone mass and bone strength rapidly deteriorate unless an antiresorptive agent is administered,' Lane told Endocrine Today...."
Media quote
October 07, 2019
"Alvogen and Pfenex’ PF708 (biosimilar, teriparatide) Receives FDA’s Approval for the Treatment of Osteoporosis @alvogenpr @Pfenex https://t.co/8CBAeOpklg"
(@Pharmashot)
FDA event
1 to 4
Of
4
Go to page
1